Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 2,823 | 3,708 | 2,120 | 2,068 | 3,923 |
| Operating Income | -2,823 | -3,708 | -2,120 | -2,068 | -3,923 |
| Other Income | 122 | -641 | 2,737 | 2,581 | -93 |
| Pre-tax Income | -2,701 | -4,349 | 617 | 513 | -4,016 |
| Net Income Continuous | -2,701 | -4,349 | 617 | 513 | -4,016 |
| Minority Interests | -9 | -9 | -23 | -13 | -9 |
| Net Income | $-2,692 | $-4,340 | $640 | $526 | $-4,007 |
| EPS Basic Total Ops | -6.43 | -15.40 | 62.11 | 4.51 | -38.74 |
| EPS Basic Continuous Ops | -2.42 | -7.74 | 62.52 | 4.75 | -38.99 |
| EPS Diluted Total Ops | -6.43 | -15.40 | 62.11 | 4.51 | -38.74 |
| EPS Diluted Continuous Ops | -2.42 | -7.74 | 62.57 | 4.70 | -38.99 |
| EPS Diluted Before Non-Recurring Items | -6.43 | -15.40 | 42.11 | 4.51 | -39.10 |
| EBITDA(a) | $-2,823 | $-3,708 | $-2,120 | $-2,068 | $-3,923 |